Nash, Richard A
High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS. [electronic resource]
- Neurology Feb 2017
- 842-852 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
1526-632X
10.1212/WNL.0000000000003660 doi
Adult
Disability Evaluation
Disease-Free Survival
Female
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Immunosuppressive Agents--administration & dosage
Magnetic Resonance Imaging
Male
Multiple Sclerosis, Relapsing-Remitting--diagnostic imaging
Transplantation, Autologous--adverse effects
Treatment Outcome